Tocqueville Asset Management L.P. Abb Vie Inc. Transaction History

Tocqueville Asset Management L.P.

$6.05 Billion
Q1 2024

A detailed history of Tocqueville Asset Management L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Tocqueville Asset Management L.P. holds 266,847 shares of ABBV stock, worth $44.3 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

266,847

Previous 269,315 0.92%

Holding current value

$44.3 Million

Previous $41.7 Million 16.43%

% of portfolio

0.8%

Previous 0.76%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $394,435 - $449,422	-2,468 Reduced 0.92%	266,847 $48.6 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $794,640 - $894,951	-5,775 Reduced 2.1%	269,315 $41.7 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $726,195 - $840,677	-5,436 Reduced 1.94%	275,090 $41 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $335,382 - $417,361	-2,531 Reduced 0.89%	280,526 $37.8 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $256,538 - $295,441	-1,774 Reduced 0.62%	283,057 $45.1 Million

Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $810,358 - $971,832	5,859 Added 2.1%	284,831 $46.1 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $269,359 - $308,937	-2,007 Reduced 0.71%	278,972 $37.4 Million
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $807,003 - $1.03 Million	5,864 Added 2.13%	280,979 $43 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $1.06 Million - $1.32 Million	-8,053 Reduced 2.84%	275,115 $44.6 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $223,454 - $282,734	2,080 Added 0.74%	283,168 $38.3 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $100,016 - $113,533	940 Added 0.34%	281,088 $30.3 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $83,641 - $93,181	795 Added 0.28%	280,148 $31.6 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $106,392 - $117,124	-1,040 Reduced 0.37%	279,353 $30.2 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $50,145 - $67,701	623 Added 0.22%	280,393 $30 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $20,360 - $23,896	237 Added 0.08%	279,770 $24.5 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $881,320 - $1.18 Million	12,012 Added 4.49%	279,533 $27.4 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $1.27 Million - $1.92 Million	-19,684 Reduced 6.85%	267,521 $20.4 Million
Q4 2019 Jan 14, 2020	SELL	$72.13 - $90.25 $737,529 - $922,806	-10,225 Reduced 3.44%	287,205 $25.4 Million
Q3 2019 Oct 31, 2019	BUY	$62.98 - $75.72 $409,684 - $492,558	6,505 Added 2.24%	297,430 $22.5 Million
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $2.53 Million - $3.24 Million	38,561 Added 15.28%	290,925 $21.2 Million
Q1 2019 Apr 30, 2019	SELL	$77.14 - $90.79 $903,772 - $1.06 Million	-11,716 Reduced 4.44%	252,364 $20.3 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $11.5 Million - $14.2 Million	-148,157 Reduced 35.94%	264,080 $24.3 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $123,140 - $136,893	-1,385 Reduced 0.33%	412,237 $39 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $6.65 Million - $7.87 Million	-74,054 Reduced 15.19%	413,622 $38.3 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $4.05 Million - $5.42 Million	-44,002 Reduced 8.28%	487,676 $46.2 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $1.03 Million - $1.13 Million	-11,467 Reduced 2.11%	531,678 $51.4 Million
Q3 2017 Oct 30, 2017	BUY	$69.85 - $89.22 $37.9 Million - $48.5 Million	543,145	543,145 $48.3 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.

Account

Tocqueville Asset Management L.P. Abb Vie Inc. Transaction History